Inte:Ligand illustration
Inte:Ligand: Your partner for in-silico drug discovery
Inte:Ligand illustration

Primary Literature

Please visit our website for an up-to-date list of publications on LigandScout .

Primary reference describing methods and algorithms

Wolber, G.; Langer, T.. LigandScout: 3-D derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. ; 2005; 45(1); 160-169.

More information on pharmacophoric alignment algorithm

Wolber, G.; Dornhofer, A. A.; Langer, T.; Efficient overlay of small organic molecules using 3D pharmacophores J. Comput. Aided Mol. Des. ; 2007; 20(12); 773-788.

Applications

Lu, X. Y.; Chen, Y. D.; Jiang, Y. J.; You, Q. D.; Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur. J. Med. Chem.; 2009; 44(9); 3718-30.
De Luca, L.; Barreca, M. L.; Ferro, S.; Christ, F.; Iraci, N.; Gitto, R.; Monforte A. M.; Debyser Z.; Chimirri A.; Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. ChemMedChem ; 2009; 4(8); 1311-6.
Ausiello, G.; Gherardini, P. F.; Gatti, E.; Incani, O.; Helmer-Citterich, M. Structural motifs recurring in different folds recognize the same ligand fragments. BMC Bioinformatics ; 2009; 10; 182.
Maccari, R.; Ottanā, R.; Ciurleo R.; Paoli, P.; Manao, G.; Camici, G.; Laggner, C.; Langer, T.; Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase. ChemMedChem ; 2009; 4(6); 957-62.
Perdih A.; Bren, U.; Solmajer, T.; Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase. J. Molec. Modeling ; 2009; 15(8); 983-996.
Barreca, M. L.; De Luca, L.; Iraci, N.; Rao, A.; Ferro, S.; Maga, G.; Chimirri, A; Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors. J. Chem. Inf. Model ; 2007; 47(2); 557-562.
Steindl, T. M; Schuster, Laggner, C.; Chuang, K.; Hoffmann, R.; Langer, T.; Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models. J. Chem. Inf. Model ; 2007; 47(2); 563-571.
Steindl, T. M; Schuster, D.; Wolber, G.; Laggner, C.; Langer, T.; High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening J. Comput. Aided Mol. Des. ; 2006; 20(12); 703-715.
Schuster, D.; Laggner, C.; Steindl, T. M.; Langer, T.; Development and validation of an in silico P450 profiler based on pharmacophore models. Curr. Drug Discov. Technol. ; 2006; 3(1); 1-48.
Steindl, T. M; Schuster, D.; Laggner, C.; Langer, T.; Parallel screening: a novel concept in pharmacophore modeling and virtual screening. J. Chem. Inf. Model ; 2006; 46(5); 2146-2157.
Krovat, E. M.; Fruhwirth, K. H.; Langer, T.; Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the Human Factor Xa. J. Chem. Inf. Model ; 2005; 45(1); 146-159.

Short Surveys

Rella, M.; A tool for automated structure-based 3D-pharmacophore generation and its application to virtual screening. Monitor - in silico. Drug Discov. Today ; 10(5):375. 2005
Dodd J.S.; Digital Briefs. Chemical & Engineering News , 83(39), September 26, 2005

Talks

Wolber, G.; Kirchmair J.; Structure-based 3D pharmacophores: An alternative to docking? Presentation at the 7th International Conference on Chemical Structures in Noordwijkerhout, 2005
Wolber, G., Langer T.; Automated structure-based pharmacophore model generation, presentation at the ACS Spring Meeting in San Diego, 2005

Contact · Disclaimer

Page designed & authored by G. Wolber

Contact · Disclaimer

© Inte:Ligand GmbH / s3